| MeSH term | MeSH ID | Detail |
|---|---|---|
| Down Syndrome | D004314 | 18 associated lipids |
| Pregnancy Complications | D011248 | 19 associated lipids |
| Cardiovascular Diseases | D002318 | 24 associated lipids |
| Ascites | D001201 | 25 associated lipids |
| Cerebrovascular Disorders | D002561 | 25 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Coronary Artery Disease | D003324 | 47 associated lipids |
| Thrombosis | D013927 | 49 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
| Liver Cirrhosis | D008103 | 67 associated lipids |
2,3-dinor, 6-keto-PGF1alpha
2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 782 references associated with 2,3-dinor, 6-keto-PGF1alpha in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 2,3-dinor, 6-keto-PGF1alpha
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
NCBI Entrez Crosslinks
All references with 2,3-dinor, 6-keto-PGF1alpha
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Rosenkranz B et al. | Effects of salicylic and acetylsalicylic acid alone and in combination on platelet aggregation and prostanoid synthesis in man. | 1986 | Br J Clin Pharmacol | pmid:3083851 |
| Regan CL et al. | Reduced fetal exposure to aspirin using a novel controlled-release preparation in normotensive and hypertensive pregnancies. | 1998 | Br J Obstet Gynaecol | pmid:9692413 |
| Reilly IA et al. | Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon. | 1986 | Br Med J (Clin Res Ed) | pmid:3083991 |
| Aitokallio-Tallberg A et al. | Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment. | 1989 | Br. J. Cancer | pmid:2803956 |
| Kaaja R et al. | Increased thromboxane production in women with a history of venous thromboembolic event: effect of heparins. | 2001 | Br. J. Haematol. | pmid:11552994 |
| Rousson D et al. | Increased in vivo biosynthesis of prostacyclin and thromboxane A2 in chronic idiopathic thrombocytopenic purpura. | 1989 | Br. J. Haematol. | pmid:2669929 |
| Ward PS et al. | Excretion of metabolites of prostacyclin and thromboxane by rats with nephrotoxic nephritis: effects of interleukin-1. | 1991 | Br. J. Pharmacol. | pmid:1933130 |
| Henrion D et al. | Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2. | 1997 | Br. J. Pharmacol. | pmid:9146891 |
| Zhao L et al. | Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. | 2009 | Br. J. Pharmacol. | pmid:19220291 |
| Aitokallio-Tallberg AM et al. | Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma. | 1991 | Cancer Res. | pmid:1868436 |
| Arvola P et al. | Exercise enhances vasorelaxation in experimental obesity associated hypertension. | 1999 | Cardiovasc. Res. | pmid:10615427 |
| Foudi N et al. | Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. | 2009 | Cardiovasc. Res. | pmid:18952694 |
| Reilly IA et al. | Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. | 1986 | Circulation | pmid:2938849 |
| Roy L et al. | Endogenous biosynthesis of prostacyclin during cardiac catheterization and angiography in man. | 1985 | Circulation | pmid:3882264 |
| Fitzgerald DJ et al. | Decreased prostacyclin biosynthesis preceding the clinical manifestation of pregnancy-induced hypertension. | 1987 | Circulation | pmid:3552297 |
| RÃ¥ngemark C et al. | Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age. | 1992 | Circulation | pmid:1423963 |
| Fitzgerald DJ et al. | The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans. | 1984 | Circulation | pmid:6428771 |
| Belton O et al. | Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. | 2000 | Circulation | pmid:10952950 |
| Brown NJ et al. | Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. | 2000 | Circulation | pmid:11056091 |
| Capone ML et al. | Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects. | 2004 | Circulation | pmid:15037526 |